Rennova Health Inc (RNVA)
0.00
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Rennova Health Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -47.47% |
| June 30, 2022 | -13.97% |
| March 31, 2022 | -198.1% |
| December 31, 2021 | |
| September 30, 2021 | -25.56K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -633.0% |
| September 30, 2020 | -317.4% |
| June 30, 2020 | |
| March 31, 2020 | -314.6% |
| December 31, 2019 | -312.6% |
| September 30, 2019 | -312.9% |
| June 30, 2019 | -330.6% |
| March 31, 2019 | -259.0% |
| December 31, 2018 | -220.4% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -9.14K% |
| December 31, 2017 | -1.58K% |
| September 30, 2017 | -1.34K% |
| June 30, 2017 | -14.32K% |
| March 31, 2017 | -7.26K% |
| December 31, 2016 | |
| September 30, 2016 | -29.03K% |
| Date | Value |
|---|---|
| June 30, 2016 | -228.5% |
| March 31, 2016 | -225.9% |
| September 30, 2015 | -824.1% |
| June 30, 2015 | -1.25K% |
| March 31, 2015 | -1.08K% |
| December 31, 2014 | -1.20K% |
| September 30, 2014 | -577.3% |
| June 30, 2014 | -1.95K% |
| March 31, 2014 | -1.17K% |
| December 31, 2013 | -1.79K% |
| September 30, 2013 | -224.3% |
| June 30, 2013 | -295.2% |
| March 31, 2013 | -295.6% |
| December 31, 2012 | -4.61K% |
| September 30, 2012 | -1.71K% |
| June 30, 2012 | -2.72K% |
| March 31, 2012 | -8.91K% |
| December 31, 2011 | |
| September 30, 2011 | -2.51K% |
| June 30, 2011 | -5.23K% |
| March 31, 2011 | -4.40K% |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | 58.18% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-25.56K%
Minimum
Sep 2021
-13.97%
Maximum
Jun 2022
-2.80K%
Average
-313.7%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Protalix BioTherapeutics Inc | -57.64% |